Rubius Therapeutics Reports Second Quarter 2020 Financial Results and Positive Progress Across Pipeline

NEXT STORY
Global In-vitro Diagnostics Market Expected to Garner $104.1 Billion by 2027 Despite the COVID-19 Global Outbreak – Exclusive Report [220 pages] by Research Dive
PREV STORY
Plus Therapeutics Reports Second Quarter 2020 Financial and Business Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Roche’s ENSPRYNG®️ (satralizumab) approved in Japan for adults and children with neuromyelitis optica spectrum disorder

author_avatar
NASDAQ Market News

FGK Clinical Research Signs Five-Year Agreement with OmniComm Systems for Multiple eClinical Products

author_avatar
NASDAQ Market News

NGM Discloses Third Oncology Development Candidate, NGM438, a Novel Antagonist Antibody Inhibiting LAIR1 for the Treatment of Advanced Solid Tumors

author_avatar
NASDAQ Market News